FMR CORP 13D and 13G filings for Turning Point Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-09 10:01 am Sale |
2022-02-08 | 13G | Turning Point Therapeutics, Inc. TPTX |
FMR CORP | 1,398,602 2.826% |
-1,775,067 (-55.93%) |
Filing |
| 2021-06-10 11:37 am Sale |
2021-06-09 | 13G | Turning Point Therapeutics, Inc. TPTX |
FMR CORP | 3,173,669 6.456% |
-3,041,693 (-48.94%) |
Filing |
| 2021-02-08 10:35 am Purchase |
2021-02-05 | 13G | Turning Point Therapeutics, Inc. TPTX |
FMR CORP | 6,215,362 12.902% |
1,374,716 (+28.40%) |
Filing |